Ptc Therapeutics, Inc.
PTCT
Revenue
186.70M
▼-23.41M▼-11.14%
3 Months ChangeAssets
1.92B
▲126.73M▲7.08%
3 Months ChangeLiabilities
2.90B
▲212.99M▲7.94%
3 Months ChangeFree Cash Flow
61.17M
▲100.93M▲253.85%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0001558370-24-013387
2024-08-08
Form 10-Q
ID: 0001070081-24-000017
2024-08-08
Form 8-K
ID: 0001070081-24-000015
2024-06-28
Form 8-K
ID: 0001070081-24-000010
2024-06-20
Form 8-K
ID: 0001558370-24-009313
2024-05-20
Form 8-K
ID: 0001558370-24-008446
2024-04-25
Form 10-Q
ID: 0001558370-24-005782
2024-04-25
Form 8-K
ID: 0001558370-24-005767
2024-02-29
Form 8-K
ID: 0001558370-24-002189
2024-01-25
Form 8-K
ID: 0001070081-24-000006